Coronavirus

Bio & Pharma Korea's SD Biosensor to supply diagnostics kits to Japan in H2

SD Biosensor Inc., South Korea’s leading in-vitro diagnostics company, has signed an agreement to supply its COVID-19 self-test kits and other...

Earnings SK Bioscience posts record earnings driven by COVID-19 vaccines

SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, has posted record 2021 revenue and operating profit, boosted by contrac...

COVID-19 SK Bioscience to sell Novavax COVID-19 vaccine in Thailand, Vietnam

SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, said on Friday it has acquired non-exclusive rights to sell US-based No...

COVID-19 Celltrion to enter clinical trials of new COVID-19 treatment

South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...

Markets Delta coronavirus variant hits global stock markets

Global stock markets lost ground on mounting fears over the spread of the Delta coronavirus variant. Record-breaking US shares riding on the hopes...

Central banking Fed’s Powell, BOK chief to meet during G20 gathering

Federal Reserve Chair Jerome Powell and Bank of Korea (BOK) Governor Lee Ju-yeol will meet during a Group of 20 (G20) gathering of finance ministe...

Bio Korea rises as production hub for coronavirus treatments; darling of global pharmas

South Korea is emerging as a global production base for coronavirus vaccines and medicine thanks to its comprehensive production facilities alongside ...

Short selling South Korean govt likely to extend short-selling ban on resurging coronavirus concerns

The South Korean government is leaning toward extending the six-month ban on short selling amid a climate of economic uncertainty, said Finance Minist...

Tech, Media & Telecom Linkflow's wearable camera helping doctors fight coronavirus

The entire city of Wuhan, China, the origin and epicenter of the novel coronavirus, is on lockdown. But medical professionals are still hard at work f...

Private equity Morgan Stanley PE cashes in on coronavirus spread in Korea

Morgan Stanley Private Equity has pocketed around 19 billion won ($16 million) in gains by cashing out a portion of its shares in a South Korean mask ...